|本期目录/Table of Contents|

[1]任之栋,张 巧,马千里.慢性阻塞性肺疾病合并肺曲霉病的诊断研究进展[J].中华肺部疾病杂志,2022,(02):272-275.[doi:10.3877/cma.j.issn.1674-6902.2022.02.037]
点击复制

慢性阻塞性肺疾病合并肺曲霉病的诊断研究进展(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2022年02期
页码:
272-275
栏目:
综述
出版日期:
2022-04-20

文章信息/Info

Title:
-
作者:
任之栋1; 张 巧2; 马千里2
400037 重庆,陆军(第三)军医大学第二附属医院呼吸内科?全军呼吸内科研究所1 401121 重庆,重庆北部宽仁医院2
Author(s):
-
关键词:
肺疾病; 慢性阻塞性;  肺曲霉菌;  进展
Keywords:
-
分类号:
R563
DOI:
10.3877/cma.j.issn.1674-6902.2022.02.037
摘要:
-
Abstract:
-

参考文献/References:

1 任成山, 王关嵩, 钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
2 Global Initiative for Chornic Obstructive Lung Disease 2020 Report[R]. 2020.
3 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 慢性阻塞性肺疾病基层诊疗指南(2018年)[J]. 中华全科医师杂志, 2018, 17(11): 856-870.
4 施 毅. 重视非粒细胞缺乏患者侵袭性肺曲霉病的临床诊治[J]. 上海医药, 2014, 35(9): 15-19.
5 胡艳艳, 张睢扬. 慢性阻塞性肺疾病与肺曲霉菌感染的研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(2): 220-223.
6 刘又宁, 余丹阳, 孙铁英, 等. 中国1998年至2007年临床确诊的肺真菌病患者的多中心回顾性调查[J]. 中华结核和呼吸杂志, 2011, 34(2): 86-90.
7 施 毅. 侵袭性肺真菌病诊治的再认识[J]. 中华结核和呼吸杂志, 2011, 34(2): 83-85.
8 Chris K, David WD. The clinical spectrum of pulmonary aspergillosis[J]. Thorax, 2015, 70(3): 270-277.
9 Claire D, Aurélie C, Emilie F, et al. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study[J]. Crit Care, 2015, 19: 421.
10 Ritesh A, Basanta H, Dheeraj G, et al. Aspergillus hypersensitivity in patients with chronic obstructive pulmonary disease: COPD as a risk factor for ABPA? [J]. Med Mycol, 2010, 48(7): 988-994.
11 Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease[J]. Eur Respir J, 2007, 30(4): 782-800.
12 Fabio ST, Anne-Marie Van den A, Pierre B, et al. Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes[J]. Critical care(London, England), 2015, 19(1): 7.
13 Tejerina EE, Abril E, Padilla R, et al. Invasive aspergillosis in critically ill patients: An autopsy study[J]. Mycoses, 2019, 62(8): 673-679.
14 Guinea J, Torres-Narbona M, Gijǘn P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome[J]. Clin Microbiol Infect, 2010, 16(7): 870-877.
15 Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: A 6-year survey[J]. Clin Infect Dis, 2006, 43(5): 577-584.
16 陈瑞英, 靳建军, 欧阳松云, 等. 非中性粒细胞缺乏患者发生侵袭性曲霉病的危险因素、临床特征及预后分析[J]. 中国实用医药, 2008, 3(15): 48-50.
17 Denning DW, Pleuvry A, Cole DC, et al. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis[J]. Eur Respir J, 2013, 41(3): 621-626.
18 Denning DW, Cadranel J, Beigelman-Aubry C, et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management[J]. Eur Respir J, 2016, 47(1): 45-68.
19 李 培, 苏 欣, 施 毅. 慢性肺曲霉病基础疾病108例回顾性分析[J]. 中国呼吸与危重监护杂志, 2018, 17(4): 348-353.
20 Hammond EE, McDonald CS, Vestbo J, et al. The global impact of Aspergillus infection on COPD [J]. BMC pulmonary med, 2020, 20(1): 241.
21 David L, Khaled Al-S, Pippa JN, et al. Predictors of mortality in chronic pulmonary aspergillosis[J]. Eur respir J, 2017, 49(2): 1601062.
22 安勇鹏, 雷军旗. 慢性阻塞性肺疾病合并侵袭性肺曲霉菌病的危险因素分析[J]. 中国临床新医学, 2018, 11(12): 1240-1242.
23 吴 克, 赵丽敏. 慢性阻塞性肺疾病合并侵袭性肺曲霉菌病临床分析[J]. 医药论坛杂志, 2019, 40(2): 12-15.
24 吴付梅, 程 华, 秦娜娜, 等. 慢性阻塞性肺疾病合并临床诊断侵袭性肺曲霉病40例回顾性分析[J]. 世界最新医学信息文摘(连续型电子期刊), 2019, 19(66): 198-199.
25 胡小燕, 王卓萍, 陈小英. 慢性阻塞性肺疾病合并侵袭性肺曲霉菌病的多因素logistic回归分析[J]. 中国基层医药, 2020, 27(8): 913-916.
26 张 蕾, 杨 青, 赵 钊, 等. 慢性阻塞性肺疾病合并侵袭性肺曲霉病的临床特征及危险因素分析[J]. 中华临床感染病杂志, 2020, 13(2): 113-118.
27 任之栋, 张 巧, 张玉江, 等. 慢性阻塞性肺疾病合并慢性肺曲霉菌病的高危因素及临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(1): 11-16.
28 He Q, Li HX, Rui YW, et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients[J]. Clin Infect Dis, 2018, 66(2): 261-267.
29 Shah MM, Hsiao EI, Kirsch CM, et al. Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature[J]. Diagnostic Micro Infect Dis, 2018, 91(2): 147-152.
30 Bulpa P, Duplaquet F, Dimopoulos G, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease exacerbations[J]. Semin Respir Crit Care Med, 2020, 41(6): 851-861.
31 Khaled Al-S, Eavan GM, Julie M, et al. Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis(CPA)[J]. Respir Med, 2016, 114: 117-122.
32 Thomas FP, George RT, David WD, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the infectious diseases society of america[J]. Clin Infect Dis, 2016, 63(4): e1-e60.
33 杨仁恒. 慢性阻塞性肺疾病并侵袭性肺曲霉菌病患者的临床表现及胸部CT表现分析[J]. 实用心脑肺血管病杂志, 2016, 24(1): 105-107.
34 程 利, 杨家友, 陈月华, 等. 慢性阻塞性肺疾病合并肺曲霉菌感染双源薄层CT图像特征及预后分析[J]. 中国CT和MRI杂志, 2019, 17(11): 45-47.
35 Silke S, Rosemary AB, Richard CB, et al. British society for medical mycology best practice recommendations for the diagnosis of serious fungal diseases[J]. The Lancet Infect Dis, 2015, 15(4): 461-474.
36 Guinea J, Torres-Narbona M, Gijón P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome[J]. Clin Microbiol Infect, 2010, 16(7): 870-877.
37 Masahito K, Yoshinobu K, Susumu G, et al. Diagnosis of pulmonary aspergillosis using optical brighteners[J]. Eur Respir J, 2000, 15(2): 407-411.
38 Zhang SZ, Wang SB, Wan Z, et al. The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay[J]. Biomed Res Int, 2015, 2015: 943691.
39 Guitard J, Sendid B, Thorez S, et al. Evaluation of a recombinant antigen-based enzyme immunoassay for the diagnosis of noninvasive aspergillosis[J]. J Clin Microbiol, 2012, 50(3): 762-765.
40 Launes C, Esteban E, Balaguer M, et al. Comparison of six aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis(CPA)[J]. J Infect, 2016, 72(2): 240-249.
41 Kappe R, Rimek D. Antibody detection in patients with invasive aspergillosis[J]. Mycoses, 2004, 47(Suppl 1): 55-59.
42 Page ID, Richardson M, Denning DW. Antibody testing in aspergillosis-quo vadis?[J]. Med Mycol, 2015, 53(5): 417-439.
43 Ma X, Wang K, Zhao X, et al. Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis[J]. BMC Infect Dis, 2019, 19(1): 694.
44 Tomer A, Itzhak L, Hannah S, et al. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review[J]. J Clin Microbiol, 2012, 50(11): 3652-3658.
45 Ascioglu S, Rex JH, Pauw B de, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[J]. Clin Infect Dis, 2002, 34(1): 7-14.
46 Ben DP, Walsh TJ, Peter DJ, et al. Revised definitions of invasive fungal disease from the european organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group(EORTC/MSG)consensus group[J]. Clin Infect Dis, 2008, 46(12): 1813-1821.
47 Vandewoude KH, Blot SI, Depuydt P, et al. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients[J]. Critical care(London, England), 2006, 10(1): R31.
48 Stijn IB, Fabio ST, Anne-Marie Van den A, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients[J]. Am J Respir Crit Care Med, 2012, 186(1): 56-64.
49 Bulpa P, Bihin B, Dimopoulos G, et al. Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD?[J]. Eur Respir J, 2017, 50(3): 1700532.
50 Huang L, He HY, Jin JJ, et al. Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/MSG and ICU criteria[J]. BMC Infect Dis, 2017, 17(1): 209.

备注/Memo

备注/Memo:
基金项目: 国家科学自然基金资助项目(81670012) 通信作者: 马千里, Email: cqmal@163.com
更新日期/Last Update: 2022-04-20